Elsevier

Brain Research

Volume 752, Issues 1–2, 28 March 1997, Pages 203-208
Brain Research

Research report
The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion

https://doi.org/10.1016/S0006-8993(96)01450-3Get rights and content

Abstract

The present study was conducted to evaluate the role of phospholipases in neuronal injury after transient focal ischemia. The phospholipase A2 (PLA2) inhibitor, quinacrine (5 mg/kg) or saline (of equal volume), was administered upon reperfusion to rats that underwent 2 h of middle cerebral artery occlusion (MCAO) via the intraluminal filament method. Rats were graded for neurological deficits based on a scale of 0–4, where 0 indicates no visible neurological deficits and 4 indicates most severe neurological deficits. After 2 h of focal ischemia, both groups of rats showed similar degrees of stroke, receiving median scores of 4. However, after 24 h of reperfusion the quinacrine treated rats (n = 18) showed significantly lower deficit scores compared to the saline controls (n = 15). Median scores were 1 and 3 and mean ranks were 12.28 and 23.14, respectively (P < 0.01, Mann-Whitney U-test). Moreover, this effect of quinacrine persisted for up to 7 days when the quinacrine treated rats continued to receive a median score of 1, whereas the saline treated rats received a median score of 2. The mean ranks were significantly lower in the quinacrine group (14.68) compared to the saline controls (21.54) (P < 0.05). After the last neurological test was conducted, the rats were sacrificed and their brains embedded in paraffin for histopathologicaal analysis. Quinacrine treated rats showed significantly reduced infarct areas in the caudoputamen compared to saline treated rats (P < 0.05, Student's t-test). When both cortical and striatal damage were summed, quinacrine treated animals also exhibited a significantly lower degree of damage compared to saline controls (P < 0.05). This study supports the notion that PLA2 plays an important role in the development of neuronal injury following transient focal ischemia.

References (34)

  • H.U. Weltzien

    Cytolytic and membrane-perturbing properties of lysophosphatidylcholine

    Biochim. Biophys. Acta

    (1979)
  • K. Abe et al.

    Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex

    J. Neurochem.

    (1987)
  • J. Astrup et al.

    Thresholds in cerebral ischemia — the ischemic penumbra

    Stroke

    (1981)
  • M. Chiariello et al.

    Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion

    J. Pharmacol. Exp. Ther.

    (1987)
  • M. Chopp et al.

    Postischemic administration of anti Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats

    Stroke

    (1994)
  • E.H. Lo et al.

    Temporal correlation analysis of penumbral dynamics in focal cerebral ischemia

    J. Cereb. Blood Flow Metab.

    (1996)
  • E.Z. Longa et al.

    Reversible middle cerebral artery occlusion without craniectomy in rats

    Stroke

    (1989)
  • Cited by (47)

    • Inhibiting ferroptosis: A novel approach for stroke therapeutics

      2021, Drug Discovery Today
      Citation Excerpt :

      No severe drug-related adverse events regarding mortality were observed [101]. Moreover, other PLA2 inhibitors, including quinacrine and arachidonyl trifluoromethyl ketone, were reported to reduce infarct size in rats following transient MCAO administration [102] and exhibited potent neuroprotection activity following spinal cord injury [103]. In general, inhibiting PLA2 exhibited promising neuroprotective ability in stroke treatment.

    • Protective effects of FBD - An experimental Chinese traditional medicinal formula on memory dysfunction in mice induced by cerebral ischemia-reperfusion

      2005, Journal of Ethnopharmacology
      Citation Excerpt :

      Taken together, this research may account for the antioxidant effect of FBD, thought to be derived from its herbal constituents and active compounds. In the development of neuronal injury following transient focal ischemia, it has been found the phospholipase A2 (PLA2) plays an important role (Estevez and Phillis, 1997). Overstimulation of this enzyme during cerebral IR results in the accumulation of bioactive metabolites such as arachidonic acid, oxygenated derivatives of arachidonic acid, and platelet-activating factor (PAF), several of these bioactive lipids participate in cell damage and death (Bazan et al., 1995).

    View all citing articles on Scopus
    View full text